Beyond molecular tumor heterogeneity: protein synthesis takes control
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond molecular tumor heterogeneity: protein synthesis takes control
Authors
Keywords
-
Journal
ONCOGENE
Volume 37, Issue 19, Pages 2490-2501
Publisher
Springer Nature
Online
2018-02-19
DOI
10.1038/s41388-018-0152-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Significance of mTOR and eIF4E Expression in Invasive Ductal Carcinoma
- (2018) Aixia Hu et al. TUMORI
- Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity
- (2017) Seraina Faes et al. Oxidative Medicine and Cellular Longevity
- Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma
- (2017) Yi-Ting Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma
- (2016) Hui Yu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Cell Competition and Its Role in the Regulation of Cell Fitness from Development to Cancer
- (2016) Aida Di Gregorio et al. DEVELOPMENTAL CELL
- Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma
- (2016) Xue-Mei Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas
- (2016) Weibing Fan et al. JOURNAL OF NEURO-ONCOLOGY
- Combination therapies in oncology
- (2016) Rachel M. Webster NATURE REVIEWS DRUG DISCOVERY
- Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation
- (2016) Celestino Velásquez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Addressing intra-tumoral heterogeneity and therapy resistance
- (2016) Brad Rybinski et al. Oncotarget
- peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
- (2016) Elena Martínez-Sáez et al. Cancer Medicine
- Signalling to eIF4E in cancer
- (2015) N. Siddiqui et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
- (2015) J. Pelletier et al. CANCER RESEARCH
- eIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion
- (2015) Shahram Khosravi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Virus-like particle-mediated intracellular delivery of mRNA cap analog with in vivo activity against hepatocellular carcinoma
- (2015) Monika Zochowska et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer
- (2015) Hyoun Wook Lee et al. PATHOLOGY RESEARCH AND PRACTICE
- Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder
- (2015) Masatomo Nishikawa et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer
- (2015) Mee Sook Roh et al. VIRCHOWS ARCHIV
- Intra-Tumour Signalling Entropy Determines Clinical Outcome in Breast and Lung Cancer
- (2015) Christopher R. S. Banerji et al. PLoS Computational Biology
- Tumor suppression by small molecule inhibitors of translation initiation
- (2015) Limo Chen et al. Oncotarget
- First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines
- (2015) Senthilmurugan Ramalingam et al. Oncotarget
- Discovery of 5-(2-(Phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one Derivatives as Potent Mnk2 Inhibitors: Synthesis, SAR Analysis and Biological Evaluation
- (2014) Sarah Diab et al. ChemMedChem
- The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets
- (2014) S. Ramon y Cajal et al. Clinical & Translational Oncology
- Expression of eukaryotic initiation factor 4 E in hypopharyngeal carcinoma
- (2014) Min Han et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Translational research in oncology—10 years of progress and future prospects
- (2014) James H. Doroshow et al. Nature Reviews Clinical Oncology
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance
- (2014) Oscar Tapia et al. VIRCHOWS ARCHIV
- Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment
- (2013) Tuomas Heikkinen et al. BREAST CANCER RESEARCH AND TREATMENT
- Interplay between the Cancer Genome and Epigenome
- (2013) Hui Shen et al. CELL
- Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor
- (2013) Jin Xu et al. ChemMedChem
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches
- (2012) Antonella De Luca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas
- (2012) Penelope Korkolopoulou et al. HISTOPATHOLOGY
- Molecular pathogenesis of mantle cell lymphoma
- (2012) Pedro Jares et al. JOURNAL OF CLINICAL INVESTIGATION
- Translational Homeostasis via the mRNA Cap-Binding Protein, eIF4E
- (2012) Akiko Yanagiya et al. MOLECULAR CELL
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- Molecular prescreening to select patient population in early clinical trials
- (2012) Jordi Rodón et al. Nature Reviews Clinical Oncology
- eIF4F suppression in breast cancer affects maintenance and progression
- (2012) Z Nasr et al. ONCOGENE
- Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia
- (2011) Tomoyuki Tsumuraya et al. BIOCHEMICAL PHARMACOLOGY
- Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007)
- (2011) Mellissa Yong et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic Inhibition of MAP Kinase Interacting Kinase Blocks Eukaryotic Initiation Factor 4E Phosphorylation and Suppresses Outgrowth of Experimental Lung Metastases
- (2011) B. W. Konicek et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer
- (2011) D. S. Hong et al. CLINICAL CANCER RESEARCH
- High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients
- (2011) Yin-Kai Chao et al. JOURNAL OF SURGICAL ONCOLOGY
- Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
- (2011) R. Cencic et al. JOURNAL OF VIROLOGY
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Prognostic significance of expression of eukaryotic initiation factor 4E and 4E binding protein 1 in patients with pathological stage I invasive lung adenocarcinoma
- (2010) Nobuhiko Seki et al. LUNG CANCER
- Translational Regulation of Gene Expression during Conditions of Cell Stress
- (2010) Keith A. Spriggs et al. MOLECULAR CELL
- Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities
- (2010) Dinesh Kumar Singh et al. Molecular Systems Biology
- High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma
- (2010) Chi-Ju Yeh et al. VIRCHOWS ARCHIV
- Cap and cap-binding proteins in the control of gene expression
- (2010) Ivan Topisirovic et al. Wiley Interdisciplinary Reviews-RNA
- Nontoxic Chemical Interdiction of the Epithelial-to-Mesenchymal Transition by Targeting Cap-Dependent Translation
- (2009) Brahma Ghosh et al. ACS Chemical Biology
- Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity
- (2009) L J Coleman et al. BRITISH JOURNAL OF CANCER
- Inhibition of eIF2α Dephosphorylation Maximizes Bortezomib Efficiency and Eliminates Quiescent Multiple Myeloma Cells Surviving Proteasome Inhibitor Therapy
- (2009) Denis M. Schewe et al. CANCER RESEARCH
- Phosphorylated 4E-BP1 Is Associated with Poor Survival in Melanoma
- (2009) K. E. O'Reilly et al. CLINICAL CANCER RESEARCH
- Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis
- (2009) Josep Castellvi et al. HUMAN PATHOLOGY
- Overexpression of Phosphorylated 4E-BP1 Predicts for Tumor Recurrence and Reduced Survival in Cervical Carcinoma Treated With Postoperative Radiotherapy
- (2009) Sergio Benavente et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma
- (2009) Rui Wang et al. LUNG CANCER
- Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A
- (2009) G. Kuznetsov et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol
- (2009) Regina Cencic et al. PLoS One
- Targeting the Eukaryotic Translation Initiation Factor 4E for Cancer Therapy
- (2008) J. R. Graff et al. CANCER RESEARCH
- The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)
- (2008) Maria Buxade Frontiers in Bioscience-Landmark
- Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro
- (2008) Silvia Darb-Esfahani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
- (2008) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Co-evolution of tumor cells and their microenvironment
- (2008) Kornelia Polyak et al. TRENDS IN GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now